Cargando…

Association between tocilizumab treatment and clinical outcomes of COVID-19 patients: a systematic review and meta-analysis

To explore and summarize the association between treatment with tocilizumab and clinical outcomes in COVID-19 patients. We performed a systematic review and meta-analysis (10 RCTs including 3378 patients in the tocilizumab group and 3142 patients in the control group). We systematically searched Pub...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Jingwen, She, Xiaodong, Mei, Huan, Zheng, Hailin, Fu, Meihua, Liang, Guanzhao, Wang, Qiong, Liu, Weida
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833131/ https://www.ncbi.nlm.nih.gov/pubmed/35038318 http://dx.doi.org/10.18632/aging.203834

Ejemplares similares

Efficacy and secondary infection risk of tocilizumab, sarilumab and anakinra in COVID‐19 patients: A systematic review and meta‐analysis
por: Peng, Jingwen, et al.
Publicado: (2021)

Fungal co-infection in COVID-19 patients: evidence from a systematic review and meta-analysis
por: Peng, Jingwen, et al.
Publicado: (2021)

Auxotrophic mutations of Trichophyton rubrum created by in vitro synthesized Cas9 ribonucleoprotein
por: Blechert, Oliver, et al.
Publicado: (2020)

The influence of the mating type on virulence of Mucor irregularis
por: Xu, Wenqi, et al.
Publicado: (2017)

Itraconazole exerts its anti-melanoma effect by suppressing Hedgehog, Wnt, and PI3K/mTOR signaling pathways
por: Liang, Guanzhao, et al.
Publicado: (2017)

Onychomycosis due to Chaetomium globosum with yellowish black discoloration and periungual inflammation
por: Shi, Dongmei, et al.
Publicado: (2016)

Chromoblastomycosis due to Fonsecaea monophora misdiagnosed as sporotrichosis and cutaneous tuberculosis in a pulmonary tuberculosis patient
por: Shi, Dongmei, et al.
Publicado: (2016)

Divergent EGFR/MAPK-Mediated Immune Responses to Clinical Candida Pathogens in Vulvovaginal Candidiasis
por: Zhang, Jingyun, et al.
Publicado: (2022)

S7.2d Divergent EGFR/MAPK-mediated immune responses to clinical Candida pathogens in vulvovaginal candidiasis
por: Zhang, Jingyun, et al.
Publicado: (2022)

Fungal Co-infections Associated with Global COVID-19 Pandemic: A Clinical and Diagnostic Perspective from China
por: Song, Ge, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19: a systematic review and meta-analysis
por: Lan, Shao-Huan, et al.
Publicado: (2020)

Tinea faciei in a newborn due to Trichophyton tonsurans
por: Fu, Meihua, et al.
Publicado: (2013)

Seborrheic dermatitis-like adult tinea capitis due to Trichophyton rubrum in an elderly man
por: Xie, Wenting, et al.
Publicado: (2023)

FK866 inhibits the epithelial-mesenchymal transition of hepatocarcinoma MHCC97-H cells
por: Zhang, Bin, et al.
Publicado: (2018)

Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: A systematic review and meta-analysis
por: Luo, Lili, et al.
Publicado: (2022)

Cardiovascular safety of tocilizumab: A systematic review and network meta-analysis
por: Castagné, Benjamin, et al.
Publicado: (2019)

Tocilizumab as treatment for COVID-19: A systematic review and meta-analysis
por: Petrelli, Fausto, et al.
Publicado: (2021)

Systematic review and meta-analysis of tocilizumab in persons with coronavirus disease-2019 (COVID-19)
por: Chen, Chong-xiang, et al.
Publicado: (2021)

Influence of the cultivation medium and pH on the pigmentation of Trichophyton rubrum
por: Blechert, Oliver, et al.
Publicado: (2019)

Mitochondrial Complex I Core Protein Regulates cAMP Signaling via Phosphodiesterase Pde2 and NAD Homeostasis in Candida albicans
por: She, Xiaodong, et al.
Publicado: (2020)

Tocilizumab treatment for COVID-19 patients: a systematic review and meta-analysis
por: Wei, Qiu, et al.
Publicado: (2021)

Different toenail onychomycosis due to Rhodotorula mucilaginosa and Candida parapsilosis in an immunocompetent young adult
por: Ge, Gai, et al.
Publicado: (2019)

Proteome-Wide Analysis of Lysine 2-Hydroxyisobutyrylation in Candida albicans
por: Zheng, Hailin, et al.
Publicado: (2021)

Safety and efficacy of tocilizumab for rheumatoid arthritis: a systematic review and meta-analysis of clinical trial studies
por: Saki, Amal, et al.
Publicado: (2021)

Effectiveness and safety of tocilizumab for COVID-19: a systematic review and meta-analysis of randomized clinical trials
por: Almeida, Paula Ribeiro Lopes, et al.
Publicado: (2022)

Use of Tocilizumab in COVID-19: A Systematic Review and Meta-Analysis of Current Evidence
por: Kotak, Sohny, et al.
Publicado: (2020)

Systematic review and meta-analysis of the current literature on tocilizumab in patients with refractory Takayasu arteritis
por: Kang, Limei, et al.
Publicado: (2023)

Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis
por: Tleyjeh, Imad M., et al.
Publicado: (2021)

Optimal use of tocilizumab for severe and critical COVID-19: a systematic review and meta-analysis
por: Nugroho, Cahyo Wibisono, et al.
Publicado: (2021)

Effectiveness of tocilizumab in the treatment of hospitalized adults COVID-19: A systematic review and meta-analysis
por: Zhang, Jing, et al.
Publicado: (2022)

Tocilizumab and Systemic Corticosteroids in the Management of Patients with COVID-19: A Systematic Review and Meta-Analysis
por: Alkofide, Hadeel, et al.
Publicado: (2021)

Efficacy and harms of tocilizumab for the treatment of COVID-19 patients: A systematic review and meta-analysis
por: Piscoya, Alejandro, et al.
Publicado: (2022)

Genetic Biomarkers as Predictors of Response to Tocilizumab in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Janahiraman, Sivakami, et al.
Publicado: (2022)

Effectiveness of tocilizumab in non-intubated cases with COVID-19: a systematic review and meta-analysis
por: Keske, Şiran, et al.
Publicado: (2023)

Efficacy of tocilizumab in patients with severe COVID-19: Survival and clinical outcomes
por: Al-Baadani, Abeer, et al.
Publicado: (2021)

Efficacy and safety of tocilizumab in COVID-19 patients
por: Zheng, Kai-Lian, et al.
Publicado: (2020)

Effect of Tocilizumab in Reducing the Mortality Rate in COVID-19 Patients: A Systematic Review with Meta-Analysis
por: Conti, Valeria, et al.
Publicado: (2021)

Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab’s Place in COVID-19 Pneumonia
por: Klopfenstein, Timothée, et al.
Publicado: (2021)

Use of tocilizumab and sarilumab alone or in combination with corticosteroids for covid-19: systematic review and network meta-analysis
por: Zeraatkar, Dena, et al.
Publicado: (2022)

Does tocilizumab have an effect on the clinical outcomes in COVID-19 patients? A meta-analysis of randomized control trials
por: Ghaempanah, Faezeh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vcacfrtjpsjrnnovbih0hodvib